AXA S.A. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2019$918,000
+72.2%
175,253
+3.7%
0.00%
+100.0%
Q4 2018$533,000
-47.9%
169,0530.0%0.00%
-50.0%
Q3 2018$1,023,000
+17.5%
169,053
+2.9%
0.00%
+33.3%
Q2 2018$871,000
+277.1%
164,293
+312.8%
0.00%
+200.0%
Q1 2018$231,00039,8000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 1,102,735$3,485,0003.61%
VHCP Management II, LLC 280,000$885,0000.53%
GREAT POINT PARTNERS LLC 550,116$1,738,0000.50%
JW Asset Management, LLC 189,919$600,0000.48%
DAFNA Capital Management LLC 140,600$444,0000.35%
Granite Point Capital Management, L.P. 186,544$589,0000.25%
SABBY MANAGEMENT, LLC 779,926$2,465,0000.13%
TFS CAPITAL LLC 159,364$504,0000.09%
Rhenman & Partners Asset Management AB 154,006$487,0000.09%
Numeric Investors LLC 1,134,931$3,586,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders